SDHA Antibodies

Santa Cruz Biotechnology offers a broad range of SDHA monoclonal antibodies for studying succinate dehydrogenase complex, subunit A (SDHA). SDHA monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SDHA plays a crucial role in the tricarboxylic acid (TCA) cycle and is essential for cellular respiration, linking the metabolic pathways of energy production. Dysregulation of SDHA has been implicated in various diseases, including certain types of cancer, making it a significant target for research. Understanding the function and regulation of SDHA can provide insights into metabolic disorders and potential therapeutic strategies. Researchers can utilize SDHA monoclonal antibodies to investigate cellular metabolism in both normal and disease states. SDHA monoclonal antibodies enable detailed examination of mitochondrial function and energy metabolism across different cell types and tissues. The high specificity of SDHA monoclonal antibodies supports precise detection and quantification in experimental settings. Santa Cruz Biotechnology monoclonal antibodies for SDHA contribute to advancing scientific understanding of cellular metabolism and disease mechanisms.